Bioactive Compounds
-
A1925 Caspase-3/7 Inhibitor I2 CitationTarget: CaspasesSummary: Caspase-3/7 inhibitor -
A3239 B-HT 920 dihydrochlorideSummary: D2 receptor agonist -
A3295 CDK9 inhibitor 2Summary: CDK9 inhibitor -
A3385 Elacridar hydrochlorideSummary: BCRP and P-GP inhibitor -
A3631 Monomethyl auristatin ESummary: A type of antimitotic agent that can also be widely used as a cytotoxic component for the preparation of antibody-drug conjugates (ADCs) for cancer research. -
A3635 MRT67307 HClTarget: TBK1|MARK1|NUAK1Summary: SIK/TBK-1/IKKe inhibitor -
A3702 ParicalcitolSummary: Analog of VD2 active form -
A3746 R1530Summary: Antiangiogenesis,mitosis-angiogenesis inhibitor (MAI) -
A3805 SCH77298418 CitationSummary: ERK1 and ERK2 inhibitor -
A3820 Simeprevir1 CitationTarget: HCV ProteasesSummary: Inhibitor of HCV NS3/4A protease

